For many months there has been a worsening shortage, or total unavailability, of cancer fighting drugs in the United States. One such drug is Taxol. Because of this shortage, vulnerable cancer patients are needlessly suffering the advance of cancer metastasis. Obviously, many are dying as a result. In what was once the most advanced nation in the world, cancer patients are suffering and dying of cancer because of drug shortages or unavailability due to what seems to be no end to the sordid conduct inflicted upon the American people.

Greedy and Indifferent Pharmaceutical Companies

Numerous media reports blame the unavailability or shortages on the refusal of pharmaceutical companies to produce the drugs because of a low profit level. In their eyes, it is OK to spend tens of millions on advertising drugs like Viagra and Cialis, that seek to increase sale of profitable drugs through continuous TV segments showing everything but the penis entering the vagina. But they have no money for dying cancer patients.

The cancer drugs are easily available from government-licensed pharmacies in Canada by oncology clinics and hospitals in the United States. But for reasons still being investigated, these cancer centers do not order the life-saving cancer drugs, such as Taxol, despite the suffering and deaths that could be avoided. Most won't even use these cancer drugs if the cancer victim buys the drugs themselves.

Government Bureaucrats in the United States

A purchasing agent in one Northern California oncology clinics advised this writer (August 29, 2011), who inquired about ordering the Taxol cancer drug.

This writer inquired of a cancer clinic, treating a woman dying of esophagus cancer, about the woman purchasing the generic Taxol cancer drug in regular use from a government-licensed pharmacy, upon the receipt of a doctor's prescription. The first two series of the generic Taxol resulted in the sudden disappearance of cancer cells. The clinic refused. Here is what the clinic representative stated to me:

I was at a conference recently, where one of the speakers talked about a big federal enforcement push against oncologists who
purchase chemotherapy drugs from outside the US (mainly Canada), and use them for patients, billing Medicare or other payors as if the drugs had been purchased in the U.S. The speaker said the government [bureaucrat] takes the view this violates FDA regulations and probably Medicare billing law as well. The feds are apparently all over this issue.

U.S. Politicians Protecting Corporations:
Americans With Cancer Die!

In 2009 President Barack Obama made a deal with major pharmaceutical companies to prevent reimportation of pharmaceuticals into the United States from Canada and other countries, even though the pharmaceuticals were either originally manufactured in the United States, or inspected and approved by major nations. Even when the drugs were life savings, and unavailable in the United States.

The Obama White House has acted for the prior two years to bar Americans and U.S. medical providers from access to government-licensed pharmacies in other countries. in 2010, President Obama supported a law known as COICA that would shut down websites of international pharmacies, the ones making available such life-saving cancer drugs as Taxol and others. That would enable U.S. pharmaceu5tical manufacturers with yearly sales in the billions to continue to fleece the public.

The carrying out of this political stunt by government bureaucrats has now resulted in cancer patients deprived access to needed treatment, and resulting in worsening of their cancer and early death.

That legislation has been followed by an even more draconian denial of treatment to cancer and other patients. That legislation had been given the somewhat bizarre name, Preventing Real Online Threats to Economic Creativity and Theft of Intellectual Property Act of 2011 (PROTECT IP Act). Even though government licensed pharmacies in countries such as Canada and throughout Europe could provide life-saving drugs in short supply or unavailable in the United States, American citizens would be deprived of obtaining such drugs, and suffer the health consequences, even death, so bribe-taking politicians in the United States can chalk up one more win for their politician-corporation relationship. And as usual, the public would be none the wiser.

Politicians as Pals to Billion Dollars a Year
U.S. Pharmaceutical Companies

As Barack Obama was campaigning to be president of the United States, he promised to support legalization of imported drugs from government-licensed pharmacies and suppliers in Canada and other nations. After Obama became president, he and Rahm Emanuel, his chief of staff, supported legislation to legalize the importation of prescription drugs from Canada and other nations. But after bribe-taking members of Congress and bribe-giving corporations applied pressure, the Obama administration and many members of Congress, reversed their position, which tended to protect the huge and obscene billion-dollars-a-year profits of many large pharmaceutical companies.

The Obama administration in December 2010, through the White House Intellectual Property Czar, Victoria Espinel, stated the administration planned to order the complete shutdown of reputable Canadian and international online pharmacy sites by pressuring U.S. companies. These companies include Google, VISA, MasterCard, and others.

In August 2011, pressure by bureaucrats in the U.S. Department of Justice caused google.com to pay a huge fine of $500,000 to the government for not succumbing to the political pressure barring Americans access to drugs from online Canadian pharmacies, which included those that were government-licensed, and capable of providing life-saving cancer drugs that U.S. drug companies had created a shortage in the United States. The threat to any U.S. company from the power wielded by U.S. politicians and bureaucrats can quickly silence anyone.

Department of Justice personnel claimed that the sale of pharmaceuticals from government-licensed pharmacies in Canada violated the

U.S. Politicians Protecting the Billions in
Corporate Profits for U.S. Drug Corporations

The new legislation, Protect Ip Act, would require Internet Service Providers and search engines to block access to all non-U.S. based online pharmacies, and prevent credit card issuers from accepting charges made from any pharmacy other than those in the United States.

Protests Based Upon Free Speech Violation